Evolution of pharmacist roles in antimicrobial stewardship: A 20-year systematic review.

IF 4.8 2区 医学 Q1 INFECTIOUS DISEASES
Vrinda Nampoothiri, Mohamed Hisham, Oluchi Mbamalu, Zubair Umer Mohamed, Sanjeev K Singh, Esmita Charani
{"title":"Evolution of pharmacist roles in antimicrobial stewardship: A 20-year systematic review.","authors":"Vrinda Nampoothiri, Mohamed Hisham, Oluchi Mbamalu, Zubair Umer Mohamed, Sanjeev K Singh, Esmita Charani","doi":"10.1016/j.ijid.2024.107306","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Whilst pharmacists are recognized as key contributors to antimicrobial stewardship (AMS) programs, the extent of their participation varies in different countries. We report a systematic review of pharmacist roles in AMS over 20 years.</p><p><strong>Methods: </strong>A systematic review of the literature describing pharmacist-led or driven AMS and its outcomes published in English between January 01, 2000, and June 30, 2020, was conducted across the main databases for research publication.</p><p><strong>Results: </strong>The analysis included 111 papers, of which 77.5% (86/111) were from high-income countries (HIC) predominantly from the USA. While pharmacist-led or driven AMS interventions were reported only from HICs in the early 2000s, the review found a progressive rise in such studies from all income settings with audit and feedback being the most frequent intervention reported. Between 2016 and 2020, studies on pharmacists-led or driven outpatient AMS and interventions related to beta-lactam or penicillin allergy were reported from HICs. Key outcomes reported include improved appropriateness of antimicrobial therapy and decreased consumption of antimicrobials.</p><p><strong>Conclusion: </strong>Existing evidence demonstrates the positive impact of pharmacists' involvement in AMS. There needs to be a concerted effort in facilitating pharmacist roles in AMS across all countries, irrespective of income setting.</p>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":" ","pages":"107306"},"PeriodicalIF":4.8000,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijid.2024.107306","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Whilst pharmacists are recognized as key contributors to antimicrobial stewardship (AMS) programs, the extent of their participation varies in different countries. We report a systematic review of pharmacist roles in AMS over 20 years.

Methods: A systematic review of the literature describing pharmacist-led or driven AMS and its outcomes published in English between January 01, 2000, and June 30, 2020, was conducted across the main databases for research publication.

Results: The analysis included 111 papers, of which 77.5% (86/111) were from high-income countries (HIC) predominantly from the USA. While pharmacist-led or driven AMS interventions were reported only from HICs in the early 2000s, the review found a progressive rise in such studies from all income settings with audit and feedback being the most frequent intervention reported. Between 2016 and 2020, studies on pharmacists-led or driven outpatient AMS and interventions related to beta-lactam or penicillin allergy were reported from HICs. Key outcomes reported include improved appropriateness of antimicrobial therapy and decreased consumption of antimicrobials.

Conclusion: Existing evidence demonstrates the positive impact of pharmacists' involvement in AMS. There needs to be a concerted effort in facilitating pharmacist roles in AMS across all countries, irrespective of income setting.

药剂师在抗菌药物管理中的角色演变:20 年系统回顾。
导言:虽然药剂师被认为是抗菌药物管理(AMS)计划的主要贡献者,但他们的参与程度在不同国家却各不相同。我们对药剂师 20 年来在抗菌药物管理中的作用进行了系统回顾:方法:我们对 2000 年 1 月 1 日至 2020 年 6 月 30 日期间以英文发表的、描述药剂师领导或推动的 AMS 及其成果的文献进行了系统性回顾,回顾范围涵盖主要的研究发表数据库:分析包括 111 篇论文,其中 77.5%(86/111)来自高收入国家(HIC),主要是美国。本世纪初,只有高收入国家(HIC)报道了由药剂师主导或推动的 AMS 干预措施,但综述发现,所有收入环境中的此类研究都在逐步增加,其中审计和反馈是报道最多的干预措施。2016 年至 2020 年期间,高收入国家/地区报告了由药剂师主导或推动的门诊病人 AMS 以及与β-内酰胺或青霉素过敏相关的干预措施的研究。报告的主要成果包括提高了抗菌药物治疗的适当性,减少了抗菌药物的消耗:现有证据表明,药剂师参与急性呼吸系统综合症治疗具有积极影响。在所有国家,无论收入背景如何,都需要共同努力促进药剂师在急性呼吸系统综合症中发挥作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
18.90
自引率
2.40%
发文量
1020
审稿时长
30 days
期刊介绍: International Journal of Infectious Diseases (IJID) Publisher: International Society for Infectious Diseases Publication Frequency: Monthly Type: Peer-reviewed, Open Access Scope: Publishes original clinical and laboratory-based research. Reports clinical trials, reviews, and some case reports. Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases. Emphasizes diseases common in under-resourced countries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信